Boundless Bio
Drug Discovery
Boundless Bio valuation and funding history | Last updated: April 4, 2023 | 1 funding rounds
Current Valuation
N/A
As of April 4, 2023
Total Funding Raised
N/A
Across 1 round
Last Round
Later Stage VC (Series C)
$100.0M
Last Funding
Apr 2023
Funding date
Capital Efficiency
N/A
Valuation / Funding
Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones
| Date | Round | Amount | Post-Valuation | Growth |
|---|---|---|---|---|
| April 4, 2023 | Later Stage VC (Series C) | $100.0M | N/A | - |
Valuation Analysis
Current Valuation Metrics
Boundless Bio is currently valued at N/A as of April 4, 2023.
What is Boundless Bio Worth in 2026?
Boundless Bio is a leading private company in the Drug Discovery sector. Track Boundless Bio's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.
How Boundless Bio Valuation is Determined
Private company valuations like Boundless Bio's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.